Atlas Trials

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT03194373 · COMPLETED

Trial details

NCT number
NCT03194373
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Head and Neck
Start date
2017-10-12
Primary completion
2019-02-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.